cholestyramine resin has been researched along with calcimycin in 1 studies
| Studies (cholestyramine resin) | Trials (cholestyramine resin) | Recent Studies (post-2010) (cholestyramine resin) | Studies (calcimycin) | Trials (calcimycin) | Recent Studies (post-2010) (calcimycin) |
|---|---|---|---|---|---|
| 2,669 | 342 | 190 | 11,946 | 40 | 444 |
| Protein | Taxonomy | cholestyramine resin (IC50) | calcimycin (IC50) |
|---|---|---|---|
| XBP1 | Homo sapiens (human) | 1.41 | |
| DNA damage-inducible transcript 3 protein | Mus musculus (house mouse) | 0.16 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kamata, K; Kasuya, Y; Kojima, S; Sugiura, M | 1 |
1 other study(ies) available for cholestyramine resin and calcimycin
| Article | Year |
|---|---|
Preservation of endothelium-dependent relaxation in cholesterol-fed and streptozotocin-induced diabetic mice by the chronic administration of cholestyramine.
Topics: Acetylcholine; Animals; Anticholesteremic Agents; Calcimycin; Cholesterol, Dietary; Cholestyramine Resin; Diabetes Mellitus, Experimental; Lipoproteins, LDL; Male; Mice; Mice, Inbred ICR; Muscle Relaxation; Streptozocin | 1996 |